Rexahn Pharmaceuticals (RNN) Rocks For 482% Gains

RNN Stock, one of the “must own” penny stocks for 2013 we covered at the end of 2012 has just come off 3 days of absolute explosiveness. Roth Capital Markets started coverage last week on RNN stock at a “Buy” rating, almost 1 year after we did when shares of the clinical stage biopharmaceutical company was trading at just 0.31. Having now gained as much as ...

Continue Reading →
14
JAN
0

Penny Stocks, Penny Stocks on the Move, Update, Volume Alerts

, , , , ,

RNN | Rexahn Pharmaceuticals Becoming A Biotech Breakout?

RNN stock, RNN stock quote, RNN stock ticker, Rexahn Pharmaceuticals Inc.NYSE MKT listed Rexahn Pharmaceuticals, Inc. (RNN) saw a nice bounce on Friday after analysts at Burrill Institutional Research initiated coverage on the biopharmaceutical penny stock. Shares in the Oncology and CNS focused biotech have been bouncing around all year, dipping recently after closing a private placement worth $6.6 million. With the new coverage initiation by the ...

Continue Reading →
29
DEC
0

Penny Stocks, Penny Stocks to Watch

, , , ,